Epidemiology and pathogenicity of M. equirhinis in equine respiratory disorders.
Abstract: Mycoplasmas are pathogens involved in respiratory disorders of various animal hosts. In horses, Mycoplasma (M.) equirhinis is the species most frequently detected in clinical respiratory specimens, with a prevalence of 12-16%, but its clinical implication in equine respiratory disorders remains unclear. Here we screened 1948 clinical specimens for the presence of M. equirhinis. The samples were both tracheal washes (TW) and bronchoalveolar lavages (BAL) collected by veterinarians in France in day-to-day work between 2020 and 2022. The samples were associated with a standardized form that served to collect key general and clinical information, such as horse age, breed, and living environment. M. equirhinis was detected using a combination of culture and post-enrichment PCR. Other diagnostic data included virology and bacteriology as well as neutrophil counts, when available. Prevalence of M. equirhinis was examined as a function of a clinical score based on four significant clinical signs (nasal discharge, cough, dyspnoea, and hyperthermia). Multivariate logistic regression analysis was run to identify risk factors for the presence of M. equirhinis, and comparative prevalence analysis was used to test for association with other bacteria and viruses. TW and BAL were analysed independently, as we found that TW samples were associated with a higher prevalence of M. equirhinis. As prevalence remained steady whatever the clinical score, M. equirhinis cannot be considered a primary pathogen. M. equirhinis was more frequently isolated in thoroughbreds and trotters and in horses living exclusively stabled compared to other horses or other living environments. M. equirhinis was never detected in BAL specimens with a 'normal' neutrophil count, i.e. 5%, suggesting it could be associated with an inflammatory response, similar to that observed in equine asthma. Prevalence of M. equirhinis was shown to increase in the presence of other bacteria such as Streptococcus equi subsp. zooepidemicus (S. zoo) or viruses, and S. zoo load was higher in M. equirhinis-positive samples, suggesting a potential increase of clinical signs in the event of co-infection.
Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.
Publication Date: 2023-11-22 PubMed ID: 38006720DOI: 10.1016/j.vetmic.2023.109926Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The study investigates the role of Mycoplasma (M.) equirhinis, a bacteria commonly found in the respiratory tracts of horses, in equine respiratory disorders. Using various diagnostic methods, the study does not find M. equirhinis as a primary cause of respiratory illness, though its prevalence differs among breeds and living conditions, and often coincides with other bacteria and viruses.
Screening of Clinical Specimens
- The researchers screened 1948 clinical samples, tracheal washes (TW) and bronchoalveolar lavages (BAL), collected by veterinarians from 2020 to 2022 in France.
- The collection was accompanied by a form detailing critical data like horse age, breed, and living conditions.
- The presence of M. equirhinis was detected through a combination of culture and post-enrichment PCR methods.
- Other diagnostic data such as virology, bacteriology, and neutrophil counts were also evaluated, when available.
Analysis and Findings
- The researchers used statistical models to study the prevalence of M. equirhinis based on clinical scores derived from four principal symptoms of respiratory illness (nasal discharge, cough, dyspnoea, and hyperthermia).
- Multivariate logistic regression was used to single out the risk factors associated with M. equirhinis infection. A comparative prevalence analysis was performed to investigate associations with other bacteria and viruses.
- The study determined that TW samples had a higher prevalence of M. equirhinis compared to BAL.
- The M. equirhinis bacterium was frequently found in specific horse breeds – thoroughbreds and trotters, as well as horses living in contained stable conditions compared to other horses or living situations.
Interpretation and Implications
- With the prevalence of M. equirhinis remaining steady despite varied clinical scores, the researchers concluded that the bacterium could not be regarded as a primary pathogen in respiratory illness in horses.
- The study suggests that M. equirhinis might be involved in an inflammatory response, similar to that seen in equine asthma, as it was never detected in BAL samples with ‘normal’ neutrophil counts.
- An increase in M. equirhinis prevalence was observed when other bacteria such as Streptococcus equi subsp. zooepidemicus (S. zoo) or viruses are present, indicating potential severity of symptoms in co-infection cases.
Cite This Article
APA
Martineau M, Kokabi E, Taiebi A, Lefebvre S, Pradier S, Jaÿ M, Tardy F, Leon A.
(2023).
Epidemiology and pathogenicity of M. equirhinis in equine respiratory disorders.
Vet Microbiol, 287, 109926.
https://doi.org/10.1016/j.vetmic.2023.109926 Publication
Researcher Affiliations
- LABÉO, Research Department, Saint-Contest, 14000 Caen, France; Univ of Caen Normandie, Univ Rouen Normandie, INSERM, DYNAMICURE UMR 1311, F-14000 Caen, France; University of Lyon, Anses, VetAgro Sup, UMR Animal mycoplasmosis, 69007 Lyon, France.
- LABÉO, Research Department, Saint-Contest, 14000 Caen, France; Univ of Caen Normandie, Univ Rouen Normandie, INSERM, DYNAMICURE UMR 1311, F-14000 Caen, France.
- LABÉO, Research Department, Saint-Contest, 14000 Caen, France; Univ of Caen Normandie, Univ Rouen Normandie, INSERM, DYNAMICURE UMR 1311, F-14000 Caen, France.
- University of Lyon, Anses, VetAgro Sup, UMR Animal mycoplasmosis, 69007 Lyon, France.
- Jolimont Veterinary Clinic, 31000 Toulouse, France.
- University of Lyon, Anses, VetAgro Sup, UMR Animal mycoplasmosis, 69007 Lyon, France.
- University of Lyon, Anses, VetAgro Sup, UMR Animal mycoplasmosis, 69007 Lyon, France. Electronic address: Florence.tardy@anses.fr.
- LABÉO, Research Department, Saint-Contest, 14000 Caen, France; Univ of Caen Normandie, Univ Rouen Normandie, INSERM, DYNAMICURE UMR 1311, F-14000 Caen, France. Electronic address: albertine.leon@laboratoire-labeo.fr.
Conflict of Interest Statement
Declaration of Competing Interest None of the authors of this paper has a financial or personal relationship with other people or organisations that could inappropriately influence or bias the content of the paper. No competing interests have been declared.
Citations
This article has been cited 0 times.Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists